AI assistant
Merck & Co., Inc. — Director's Dealing 2018
May 8, 2018
284_dirs_2018-05-08_1fdbfb3e-c00e-4b98-81b9-7c16352c4d65.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-04
Reporting Person: Watson Ashley (SVP Chief Ethics & Com Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-04 | Restricted Stock Unit | $ | A | 2597.0000 | Acquired | 2021-05-04 | Common Stock (2597.0000) | Direct |
| 2018-05-04 | Stock Option (right to buy) | $57.7500 | A | 18298.0000 | Acquired | 2028-05-03 | Common Stock (18298.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 9631.7210 | Direct |
| Common Stock - 401(k) Plan | 189.5810 | Indirect |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Includes shares acquired and dividends earned through May 1, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
F5: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.